Enovis (ENOV) EPS (Diluted) Growth (1y) (2011 - 2026)
Enovis (ENOV) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 95.96% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.19% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.80% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 69.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 69.08% |
| Dec 31, 2025 | -475.42% |
| Oct 3, 2025 | -101.74% |
| Jul 4, 2025 | -31.31% |
| Dec 31, 2024 | 3,399.54% |
| Sep 27, 2024 | -86.77% |
| Jun 28, 2024 | -101.41% |
| Dec 31, 2023 | -99.93% |
| Sep 29, 2023 | 3,228.16% |
| Jun 30, 2023 | 110.99% |
| Mar 31, 2023 | -102.07% |
| Dec 31, 2022 | 10.06% |
| Sep 30, 2022 | -102.02% |
| Jul 1, 2022 | -245.27% |
| Apr 1, 2022 | -31.39% |
| Dec 31, 2021 | 270.93% |
| Oct 1, 2021 | 65.20% |
| Jul 2, 2021 | 396.56% |
| Apr 2, 2021 | 324.76% |
| Dec 31, 2020 | 85.35% |